Myeloid C-type lectin receptors (CLRs), which consist of an extracellular carbohydrate recognition domain and intracellular signal transducing motif such as the immunoreceptor tyrosine-based activation motif (ITAM) or immunoreceptor tyrosine-based inhibitory motif (ITIM), are innate immune receptors primarily expressed on myeloid lineage cells such as dendritic cells (DCs) and M s. CLRs play important roles in host defense against infection by fungi and bacteria by recognizing specific carbohydrate components of these pathogens. However, these immune receptors also make important contributions to immune homeostasis of mucosa and skin in mammals by recognizing components of microbiota, as well as by recognizing self-components such as alarmins from dead cells and noncanonical non-carbohydrate ligands. CLR deficiency not only induces hypersensitivity to infection, but also causes dysregulation of muco-cutaneous immune homeostasis, resulting in the development of allergy, inflammation, autoimmunity, and tumors. In this review, we introduce recent discoveries regarding the roles of myeloid CLRs in the immune system exposed to the environment, and discuss the roles of these lectin receptors in the development of colitis, asthma, psoriasis, atopic dermatitis, and cancer. Although some CLRs are suggested to be involved in the development of these diseases, the function of CLRs and their ligands still largely remain to be elucidated.
TA B L E 1 Myeloid C-type lectin receptors in mice
or expressed on tumor cells. 18 Hence, in this review, we will discuss the roles of myeloid CLRs in the development of diseases of the skin and mucoepithelial tissues as well as in the development of tumors.
MYELOID CLRS IN INTESTINAL MUCOSAL IMMUNITY

Colitis
To maintain mucosal homeostasis, the intestinal immune system has to deal with contradictory requirements; the system must be tolerant 
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The roles of CLRs in intestinal mucosal homeostasis. When the intestinal epithelial barrier is damaged by pathogen infection or physical or chemical injury, microbiota in the intestinal lumen invade the lamina propria, causing inflammation. CLRs are important for the protection against fungal and bacterial infection. Upon Candida infection, DECTIN-1 induces reactive oxygen species (ROS), antimicrobial protein/peptides (AMPs), and Th17 cell differentiation through activation of the SYK-CARD9-NF-B pathway in order to eradicate the pathogen. SIGN-R3 expressed on myeloid-derived cells binds intestinal fungi by recognizing fungal glycan structures. DECTIN-1 expressed on myeloidderived cells also recognizes food-derived -glucans to induce IL-17F, which stimulates epithelial cells to secret antimicrobial protein S100A8 and phospholipase A2 to inhibit the growth of Lactobacillus murinus and Clostridium cluster XIVa, respectively. Both Lactobacillus and Streptococcus are recognized by MGL1 and induce IL-10 and TGF-, promoting the expansion of Treg cells and also directly suppressing inflammation. Clostridium XIVa also induces Treg differentiation by producing short-chain fatty acids (SCFA). On the other hand, DECTIN-1 expressed on human intestinal epithelium induces the production of IL-8 and CCL2 after -glucan stimulation, which may recruit neutrophils to mediate inflammation Deficiency of CARD9, a downstream adaptor protein of ITAMmediated CLR signaling, also causes intestinal fungal expansion and aggravates colitis; oral inoculation of Lactobacillus murinus can ameliorate this intestinal inflammation. 26 The authors of that study suggested that reduced levels of IL-22, which is important for the recovery from colitis, is responsible for the increased susceptibility to colitis rather than increased fungal growth in Card9 -/-mice, and showed that IL-22 is induced by aryl hydrocarbon receptor ligands produced by commensal bacteria including Lactobacillus family members. 26 DECTIN-1 is expressed in freshly isolated human intestinal epithelial cells (IECs) and human IEC lines, but not in the analogous mouse cells. 27 Stimulation of human IECs with -glucans induces IL-8 and CCL2 secretion, which can be blocked by SYK inhibition, 27 suggesting involvement of IECs in the development of colitis in humans. CLEC7A expression is up-regulated in inflamed colons of IBD patients, 28 and 2 single-nucleotide polymorphisms in CLEC7A are correlated with medically refractory ulcerative colitis. 21 Thus, DECTIN-1 plays important roles not only in host defense against infection, but also in maintaining intestinal homeostasis under physiological conditions (Fig. 1) . However, additional studies are still needed to fully understand the roles of this molecule completely in the homeostasis of human intestinal immunity.
Other myeloid CLRs are also implicated in the development of colitis. MGL1, expressed in colonic lamina propria F4/80-high cells, binds Streptococcus species and Lactobacillus species to induce IL-10 production in vitro. 29 Mice lacking this molecule develop more severe inflammation after DSS-treatment, accompanied with impaired IL-10 secretion. 29 Although MCL and DCIR also bind some intestinal commensal microbiota, mice deficient in these molecules develop slightly more severe DSS-induced colitis. 30 Another report showed that DCIR-deficient mice develop even milder colitis, with reduced neutrophil-attracting chemokine MIP-2 and decreased accumulation of neutrophils. 31 MR-expressing mouse intestinal M s contribute to wound healing in DSS-induced colitis. 32 SIGN-R1, the mouse homolog of human DC-SIGN, synergizes with TLR4 to respond to LPS, and deficiency of SIGN-R1 impairs commensal bacteria-induced pro-inflammatory cytokine production and attenuates intestinal inflammation after DSS administration. 33 Another DC-SIGN homolog, SIGN-R3, also recognizes glycan structures on commensal fungi and Mycobacterium tuberculosis. Mice deficient in this molecule are more sensitive to M. tuberculosis infection and develop more severe colitis with an enhanced TNF production. 34 The detailed functional roles of these myeloid CLRs remain to be elucidated.
MYELOID CLRS IN PULMONARY MUCOSAL IMMUNITY
Asthma and allergic diseases
Asthma, one of most common chronic respiratory diseases, is associated with airway inflammation and remodeling. Possible alterations of asthmatic patient airway structure include mucous gland and goblet cell hyperplasia, modification of epithelial cells, subepithelial fibrosis, constriction of airway smooth muscle, and changes in blood vessels. 35 Numerous cytokines, including IL-9, IL-13, IL-17, IL-22, IL-25, and other inflammatory mediators, are involved in the airway remodeling. 36, 37 Despite being classified as a single disease, the term "asthma" subsumes pathologically distinct complex diseases, often accompanied by other morbidities, complicating patient state and decisions about treatment regimen. 38 Frequently, asthma originating in childhood may continue at older ages. To a large extent, asthma developed in children is associated with allergy and atopic disease. Atopic asthma is caused by type 2 immune responses with enhanced IgE production, followed by eosinophilia and mast cell activation. 39 Asthma can also be diagnosed at any age in adulthood. However, the majority of adult-diagnosed asthma is Th2-low and non-atopic, and is often associated with high neutrophil concentrations and elevated Th17-related responses. 40, 41 Importantly, Th2-high and Th2-low forms of asthma exhibit distinct responses to corticosteroid treatment; Th2-high asthmatics respond to this treatment, whereas Th2-low patients are refractory. 38 CLRs are thought to be involved in both forms of asthma (Fig. 2) .
3.1.1
Aspergillus fumigatus-associated asthma Among other CLRs, DC-SIGN, the receptor for galactomannans, is also suggested to take part in Aspergillus fumigatus-induced immune
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F I G U R E 2 The roles of CLRs in asthma.
Ags from Aspergillus fumigatus and HDM activate DCs to induce differentiation of Th2 cells, resulting in the development of Th2-high asthma through activation of mast cells, eosinophils, NH cells, ILC2s, and basophils. On the other hand, PAMPs from these microbes activate CLRs such as DECTIN-1 and DECTIN-2, leading to the differentiation of Th17 cells and activation of T cells and ILC3s. IL-17A and IL-17F produced in these cells induce inflammation in the lungs by recruiting neutrophils, that is a characteristic of Th2-low, steroid resistant asthma. IL-22 produced in these cells, as well as IL-17A and IL-17F, is involved in mucus production and epithelial proliferation. DECTIN-1, DECTIN-2, MR, and DC-SIGN also take part in the activation of Th2 cells, facilitating the development of Th2-high, steroid-sensitive asthma responses by recognizing galactomannans on Aspergillus fumigatus. 54, 62 However, its role in allergy-related processes remains to be elucidated.
HDM-associated asthma
HDMs are another widespread cause of AHR response and allergy. 63 
HDM allergens include proteases of Dermatophagoides pteronyssinus
(Der p 1, Der p 3, Der p 6, and Der p 9) and of Dermatophagides farina (Der f 1 and so on), which can induce production of inflammatory cytokines, breakage of epithelial barriers, and stimulation of airway smooth muscle proliferation in asthmatic patients. 63 Components of HDM extract also trigger cysteinyl leukotriene generation by CD11c + DCs through the activation of the DECTIN-2-SYK pathway, 56 and activates Th2 immune responses. 55 
MYELOID CLRS IN CUTANEOUS IMMUNITY
Psoriasis
Psoriasis is a chronic inflammatory skin disease characterized by thickening and redness of the skin associated with keratinocyte hyperproliferation, skin inflammation with inflammatory cell infiltration in the epidermis and dermis, and (in severe cases) aseptic abscess formation. 73 Cytokines such as IL-23, IL-17A, and TNF play important roles for the pathogenesis of the disease, and the Abs against these cytokines are effective in treating the disease. 74 including TNF, G-CSF, IL-1 , CXCL1, and CXCL2 from keratinocytes and fibroblasts, causing inflammation and promoting keratinocyte proliferation, ultimately resulting in hyperplasia of the skin (Fig. 3) .
The antimicrobial protein LL37, which is produced by keratinocytes, is thought to activate TLR7 and TLR8 by forming a complex with RNA. 82 Thus, innate immune responses, but not acquired immune responses, may play central roles in the development of psoriasis. After initiation of inflammation, however, various inflammatory cytokines may also activate immune cells of the acquired immune system, enhancing the inflammatory processes by forming an amplification loop.
Involvement of CLRs is also suggested in the development of psoriasiform dermatitis and arthritis in SKG mice. Administration of -glucans or mannans evokes these symptoms in these mice, which do not develop any symptoms under SPF conditions, and the development of arthritis is suppressed in Clec7a -/-mice, suggesting that innate immunity triggers the development of Ag-dependent autoimmunity. 83, 84 Innate immune signaling has been suggested to activate complement pathways and produce C5a, which stimulates M s to produce IL-6 and GM-CSF, which in turn promote Th17 differentiation. 85 
Atopic dermatitis
AD is a chronic inflammatory skin disease associated with intense itch and recurrent eczematous lesions. The pathophysiology of AD is complex and multifactorial, and barrier dysfunctions of the skin such as caused by mutations in FILAGGRIN and enhanced cell-and IgEmediated immune responses caused by sustained infection of bacteria and fungi are thought to be critically involved in the pathogenesis. 90, 91 AD patients have an elevated susceptibility to infection with bacteria, fungi, and viruses, 90, 91 and CLRs play important roles in the protection of pathogen invasion and pathogenesis of dermatitis.
Among these pathogens, the best characterized is Staphylococcus aureus, which is detected in approximately 90% patients and is associated with disease exacerbation. The non-myeloid CTL mannosebinding lectin contributes to defense against this bacterium by activating the complement lectin pathway via an interaction with specific polysaccharide structures. Malassezia, a commensal fungus on the skin, is also thought to cause AD by producing a variety of immunogenic proteins that elicit specific IgE immune responses. 92, 93 MINCLE, expressed on activated phagocytes, can recognize -mannosyl residues on Malassezia, resulting in the activation of M s to produce inflammatory cytokines and chemokines. 94 Mast cells from AD patients also express MINCLE, and upon exposure to Malassezia, Mincle expression, and IL-6 secretion are enhanced. 95 DECTIN-1 expression is higher in AD skin compared to healthy skin. 6 However, stimulation of Dectin-1 expression by Malassezia or IgE crosslinking is impaired in AD-derived mast cells, 6 
MYELOID CLRS IN TUMOR IMMUNITY
CONCLUDING REMARKS
In this review, we described the roles of myeloid CLRs in diseases of muco-epithelial tissues. Recent progress in research on myeloid
CLRs has revealed that in addition to the host defense against pathogens, these molecules play important roles in the homeostasis of muco-epithelial immunity and development of diseases, including colitis, asthma, psoriasis, atopic dermatitis, and cancers. 
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